NIH-funded research R01 grant

Investigating how microglia affect cognitive and motor issues in Parkinson's disease

Official title: The role of microglia in Parkinson's disease cognitive and motor impairment

Funded at Johns Hopkins University · NIH-11048361 · Data updated 2026-11-12

This study is looking at how brain immune cells called microglia might affect the symptoms of Parkinson's disease in people who are just starting to experience it, with the hope of finding better ways to diagnose and treat the condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startJanuary 1, 2025
Project endDecember 31, 2029
Funding year2025
Award (this year)$670,600
NIH project number1R01NS136702-01A1
Project IDNIH-11048361 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with early-stage Parkinson's disease or mild cognitive impairment related to Parkinson's.

Less likely to help

Patients with advanced Parkinson's disease or those without cognitive or motor impairments may not benefit from this research.

What this research studies

This research focuses on understanding the role of microglia, a type of immune cell in the brain, in the progression of Parkinson's disease (PD) and its associated cognitive and motor impairments. By using a specialized imaging technique that targets microglial activation, the study aims to explore how these cells contribute to the severity of symptoms in patients with early-stage PD and mild cognitive impairment. Patients will undergo imaging to assess microglial activity, which may help identify common mechanisms that drive disease progression across different forms of PD. The ultimate goal is to develop better diagnostic tools and potential therapeutic strategies for managing PD.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients suffering from cognitive and motor impairments associated with Parkinson's disease.

How similar studies have gone: Previous research has shown promising results in understanding microglial activation in neurodegenerative diseases, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Mills, Kelly Alexander — Johns Hopkins University
  • Study coordinator: Mills, Kelly Alexander

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.